Clinical Trials for Small Cell Lung Cancer

Find clinical trials for small cell lung cancer. Discover research opportunities and treatment options in your area.

62 Active Trials Found

Showing 62 trials on this page

Page 3 of 4

Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Advanced Small Cell Lung Cancer

NCT ID: NCT06283719

This clinical trial is studying a new treatment called ZG006 for patients with advanced small cell lung cancer or neuroendocrine carcinoma. The research is divided into two parts. In the first part...

Recruiting

Phase: PHASE1 Type: interventional Locations: Shanghai, Shanghai, China

Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma

NCT ID: NCT05978284

This clinical trial is studying a new treatment called ZG006 for patients with small cell lung cancer or neuroendocrine carcinoma who have not had any standard treatment options available, or who w...

Recruiting

Phase: PHASE1 Type: interventional Locations: Zhengzhou, Henan, China

A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors

NCT ID: NCT06724263

This clinical trial is testing a new treatment called B1962 for patients with advanced solid tumors, including types of cancer like recurrent ovarian cancer, triple-negative breast cancer, cervical...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, Shanghai, China

ARTEMIS-008：HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer

NCT ID: NCT06498479

The ARTEMIS-008 clinical trial is studying a new treatment called HS-20093 to see how well it works compared to the standard medication, Topotecan, for people with relapsed small cell lung cancer (...

Recruiting

Phase: PHASE3 Type: interventional Locations: Beijing, , China, Wuhan, Hubei, China +7 more

Safety and Efficacy of NEO212 in Patients with Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

NCT ID: NCT06047379

This clinical trial is exploring a new treatment called NEO212 for patients with specific types of brain tumors, including Astrocytoma IDH-mutant and Glioblastoma IDH-wildtype, as well as other sol...

Recruiting

Phase: PHASE1 Type: interventional Locations: Tacoma, Washington, United States, Beverly Hills, California, United States

JK-1201I Compared with Topotecan in Patients with Relapsed Extensive Stage Small Cell Lung Cancer

NCT ID: NCT06581380

This clinical trial is looking to compare a new treatment called JK-1201I with an existing medication called Topotecan for patients who have relapsed extensive stage small cell lung cancer (ES SCLC...

Not yet recruiting

Phase: PHASE3 Type: interventional

A Study of BL-M14D1 in Patients With Locally Advanced or Metastatic Small Cell Lung Cancer, Neuroendocrine Tumors and Other Solid Tumors

NCT ID: NCT06505824

This clinical trial is studying a new treatment called BL-M14D1 for patients with advanced small cell lung cancer, neuroendocrine tumors, and other solid tumors that are hard to treat or don’t have...

Recruiting

Phase: PHASE1 Type: interventional Locations: Shanghai, Shanghai, China

Serplulimab Combined With CCRT for LS-SCLC.

NCT ID: NCT06295926

This clinical trial is studying a new treatment approach for limited-stage small cell lung cancer (LS-SCLC) by combining an immunotherapy drug called Serplulimab with concurrent chemoradiotherapy (...

Recruiting

Phase: PHASE2 Type: interventional Locations: Beijing, Beijing, China

Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.

NCT ID: NCT05271292

This clinical trial is studying a new medication called chiauranib to see how well it works for patients with advanced solid tumors, particularly those with small cell lung cancer (SCLC) that has n...

Recruiting

Phase: PHASE1 Type: interventional Locations: Atlanta, Georgia, United States, Detroit, Michigan, United States +9 more

Phase 2 Safety and Efficacy Evaluation of AL8326 in ≥2nd Line SCLC

NCT ID: NCT05363280

This clinical trial is studying a new treatment called AL8326 for patients with small cell lung cancer (SCLC) who have already received at least one prior treatment. AL8326 is a type of medication ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Birmingham, Alabama, United States, Cleveland, Ohio, United States +4 more

Liposomal Irinotecan Combination Regimen for First-line Treatment of Small Cell Lung Cancer

NCT ID: NCT06462105

This clinical trial is investigating a new treatment approach for patients with extensive stage small cell lung cancer (SCLC), a type of lung cancer that tends to spread quickly and is often diagno...

Not yet recruiting

Phase: NA Type: interventional

Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer

NCT ID: NCT06467786

This clinical trial is studying a new treatment approach for small cell lung cancer, specifically looking at the effects of a drug called irinotecan liposomes when combined with other chemotherapy ...

Recruiting

Phase: PHASE4 Type: interventional Locations: Xi'an, Shannxi, China

Patient-derived Organoid Drug Sensitivity Guided Treatment for Recurrent Small Cell Lung Cancer

NCT ID: NCT06406660

This clinical trial is exploring a new way to treat patients with recurrent small cell lung cancer, a type of lung cancer that comes back after treatment. The study aims to enroll 20 patients who a...

Recruiting

Phase: NA Type: interventional Locations: Zhengzhou, Henan, China

Efficacy and Safety of DEB-BACE Combined With Serplulimab in First-line Treatment of SCLC

NCT ID: NCT06364046

This clinical trial is studying a new treatment approach for small cell lung cancer (SCLC), a type of lung cancer. Researchers want to compare two treatment methods: one involves using a technique ...

Not yet recruiting

Phase: NA Type: interventional Locations: Lishui, Zhejiang, China

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

NCT ID: NCT05563272

This clinical trial is studying a special imaging technique using a substance called 89Zr-girentuximab to help doctors see certain types of solid tumors more clearly. The goal is to find out how we...

Recruiting

Phase: PHASE2 Type: interventional Locations: Cleveland, Ohio, United States, Spokane, Washington, United States +3 more

Efficacy and Biomarker Explanation of IBI-322 Plus Lenvatinib on Extensive Stage Small Cell Lung Cancer

NCT ID: NCT05296603

This clinical trial is studying a combination treatment of IBI-322 and Lenvatinib for patients with extensive stage small cell lung cancer (SCLC) who did not respond well to their first treatment w...

Recruiting

Phase: PHASE2 Type: interventional Locations: Changsha, Hunan, China

SC0245 and Irinotecan in Treating Patients With Relapsed Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

NCT ID: NCT05731518

This clinical trial is investigating a new treatment for patients with extensive-stage small cell lung cancer (ES-SCLC) who have not responded to previous therapies. The study is looking at a combi...

Recruiting

Phase: PHASE1 Type: interventional Locations: Shanghai, Shanghai, China

IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors

NCT ID: NCT05780307

This clinical trial, called IMM2520, is testing a new treatment for patients with advanced solid tumors, including lung, breast, and colorectal cancers. The main goal is to see how safe the treatme...

Recruiting

Phase: PHASE1 Type: interventional Locations: Jinan, Shandong, China

Surufatinib Combined With Serplulimab Plus Chemotherapy in the Treatment of Extensive-stage Small Cell Lung Cancer

NCT ID: NCT05882630

This clinical trial is looking at a new treatment approach for patients with extensive-stage small cell lung cancer (ES-SCLC), which is a type of lung cancer that has spread beyond the lungs. The r...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Fuzhou, Fujian, China

Panomic Approach to Immune-Connected Assays in Small Cell Lung Cancer

NCT ID: NCT05797493

The PICASSO project is a clinical trial designed to study small cell lung cancer (SCLC) using advanced techniques to understand the disease better and how the immune system responds to it. Research...

Recruiting

Type: observational Locations: Rome, , Italy

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions